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INTRODUCTION
Hemorrhagic fever with renal syndrome (HFRS), caused
by Hantaviruses (family Bunyaviridae, genus Hantavirus), is
a rodent-borne zoonosis widely distributed over Europe and
Asia. More than 20 strains of Hantaviruses are known world-
wide, but not all strains are associated with human disease.
Among Hantaviruses, the major causative agents are Hantaan,
Seoul, and Puumala viruses (1-3). In the Republic of Korea
(ROK), both Hantaan and Seoul viruses are known as the
etiologic agents of HFRS. These viruses establish chronic
infections in certain species of rodents and are transmitted to
man primarily via aerosols or fomites from feces, urine, and
saliva of infected mice (2-4). Hantaan virus, carried by Apode-
mus agrarius and Apodemus peninsulae, causes a severe form of
HFRS and is mostly distributed in rural areas, whereas Seoul
virus, carried by domestic (Rattus norvegicus and Rattus rattus)
and laboratory rats, causes urban and laboratory-acquired cases
respectively and may cause a milder clinical syndrome (5, 6). 
HFRS is characterized by a triad of fever, hemorrhagic man-
ifestations including petechiae, and renal impairment, but
there are marked variations in the severity, duration, and de-
gree of each organ involvement. In general, patients complain
of abrupt fever, eye symptoms, gastrointestinal symptoms,
and other nonspecific constitutional symptoms. Therefore,
diagnosis must be confirmed by serologic tests (3, 7-9). 
HFRS is one of the important acute febrile infections dur-
ing autumn and a major public health problem in the ROK.
It was recognized for the first time in Korea in 1951 among
soldiers of the United Nations (10). The causative pathogen
‘Hantaan virus’ was discovered by Lee et al. in 1976 (5, 11)
and named after the Hantaan River crossing the endemic
areas near the demilitarized zone (DMZ) between North and
South Korea. 
There are two epidemic periods of HFRS each year, the
major (October-December) and minor epidemic periods (May-
July). The majority of cases (more than 75% of patients) occur
during the major epidemic period. Seoul virus infection is
less seasonal in occurrence. There are two high-risk groups
of HFRS; residents in the northern part of the country, who
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Epidemiology of Hemorrhagic Fever with Renal Syndrome in Endemic
Area of the Republic of Korea, 1995-1998
We conducted an epidemiologic study to understand temporal and spatial patterns
of hemorrhagic fever with renal syndrome (HFRS) in the Republic of Korea (ROK).
We estimated the incidence among civilians in endemic areas through the active
surveillance system during the major epidemic periods, from September to Decem-
ber, between 1996 and 1998. We also estimated the prevalence among Korean
military personnel from 1995 to 1998. In addition, we assessed seroprevalence, sub-
clinical infection rate, and vaccination rates in both civilians and military personnel.
The incidence in civilians ranged from 2.1 to 6.6 per 100,000 person-months. The
annual prevalence in the military personnel was 40-64 per 100,000 military popula-
tions, and remained generally constant throughout the study period with seasonal
variation. This is the prospective epidemiologic data set on HFRS in the ROK since
the inactivated Hantaan virus vaccine was licensed for use in the late 1990s. These
results will be invaluable in establishing a national immunization program against
HFRS.
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are mostly farmers, and Korean soldiers stationed in the field
(9, 12-14).
More than 500 HFRS cases were serologically confirmed
and hospitalized annually in the 1980s (9). However, the
number of the reported cases has gradually decreased to appro-
ximately 300-400 cases per year since it was legally designated
as a communicable disease in 2000 (15). Nevertheless, the
associated factors have not been defined. The inactivated Han-
tavirus vaccine (Hantavax
�, Korean Green Cross, Korea) has
been commercially available since October 1990. Since its
adoption into the national immunization program in 1992, it
has been widely distributed to public health centers and the
Korean army. Because the vaccine has not been evaluated for
efficacy in a controlled trial, the protective effect of the vaccine
is still under debate (16-19). Moreover, there are only a few
published data on the incidence or prevalence of HFRS (20).
In this study, we conducted an epidemiologic suwey of HFRS
in the ROK. We estimated the incidence, prevalence, subclini-
cal infection, vaccination rate, and seroprevalence in high-risk
groups--civilians in the endemic areas and Korean military
personnel.
MATERIALS AND METHODS
Study areas
Civilians
We developed a HFRS surveillance system in two neigh-
boring endemic areas, Yeoncheon and Paju, with a population
of approximately 55,000 and 178,000, respectively, where
many cases of HFRS have been reported for the past years.
These areas are typical farm villages, located in mountainous
districts of the northernmost of Gyeonggi province. The Han-
taan River flows through the southeast part of Yeoncheon
(Fig. 1). Each village is served by a public health clinic that
provides centralized support for the village-run immuniza-
tion program and health care. 
Military personnel
We collected and analyzed HFRS cases in Korean military
troops throughout the country. 
Study design 
The research team included infectious disease specialists of
Korea University Medical Center, two epidemiologists, a vi-
rologist, and a medical officer. Cases of HFRS were identified
through active surveillance systems, described below. Seroepi-
demiologic surveys were carried before and after the major or
minor epidemic period to assess subclinical infection rate and
seroprevalence. Vaccination rates were also assessed in both
study groups. 
Definition
A confirmed case of HFRS was defined as a patient with
symptoms and signs comparable to acute stage of HFRS and
positive indirect immunofluorescent antibody test (IFA) for
Hantaan virus: four-fold rising antibody titers or seroconver-
sion in the paired sera. A case of subclinical infection was de-
fined as a person who showed the positive IFA criteria with-
out any history of febrile illness or vaccination. Seroprevalence
at a point in time was represented as percentage of cases show-
ing ≥1:32 with IFA in the unvaccinated population for the
past three years.
Active surveillance system
An active surveillance system was established in the Yeon-
cheon Medical Center from 1996 to 1998 and another was es-
tablished in the Paju Public Health Center in 1998. The study
period for each year was from September to December (Fig. 2).
The system actively searched for acute febrile patients whose
clinical features were compatible with HFRS. Reporting sources
included the public health center and public health clinics,
private clinics, and hospitals in each area. The study team reg-
ularly contacted reporting institutes once a week to elicit re-
ports, including negative reports. Paired sera (acute and con-
valescent phases) were collected from all reporting patients for
serologic tests. The study team also reviewed medical records
of HFRS from six hospitals in adjacent areas to discover cases
who might have escaped the surveillance system. 
As for the Korean military personnel, we used the HFRS
surveillance system from January 1995 to December 1998,
which had already been established in the Armed Forces Capi-
tal Hospital (AFCH); all HFRS cases, including suspected
cases, in the military troops were to be sent to the AFCH. We
reviewed medical records of the reported cases. 
Seroepidemiologic surveys
Surveys in civilians were conducted in both Yeoncheon and
Fig. 1. Study areas, Yeoncheon and Paju, which are located in the
northernmost part of Gyeonggi province, Republic of Korea. ADL,
armistice demarcation line (      ); DMZ, demilitarized zone (      ).
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Paju areas during the major epidemic periods from 1997 to
1998. Paired sera were obtained in August and the following
February of each year. Written questionnaires were given to
each subject. The questionnaire included past history of HFRS,
HFRS vaccination for the past three years, and any febrile ill-
ness experienced during the study periods.
As for the military personnel, paired sera were obtained
from the unvaccinated, healthy volunteers in March and in
August 1995 for the minor epidemic period and in August
1996 and in February 1997 for the major epidemic period.
Subclinical infection rates were calculated per epidemic period.
Vaccination records
Since vaccination for HFRS has been done exclusively at
public health centers and public health clinics, we reviewed
HFRS vaccination records of civilians (≥20 yr-old) from the
public health centers in Yeoncheon (1996 to 1998) and Paju
(1997 to 1998). As for the military personnel, we reviewed
vaccination records of four divisions in which more than 10
cases of HFRS per year have been reported during the past
five years.
Serologic test
Indirect immunofluorescent antibody assay for Hantaan
virus was performed by an expert at the Institute of Viral Dis-
eases, Korea University, Seoul, ROK (21). Serum samples with
titers ≥1:32 were considered positive, but paired sera were
required to assess current or subclinical infection.
Data analysis
Incidence in civilians of Yeoncheon was calculated for the
major epidemic periods from 1996 to 1998 by taking the
number of new HFRS cases reported during the study peri-
od and dividing by the four-month Yeoncheon population;
represented as 100,000 person-months. Incidence in those
of Paju was calculated similarly. The annual prevalence in the
military personnel was calculated from 1995 to 1998 by tak-
ing all the HFRS cases reported each year and dividing by
the 100,000 military populations. 95% confidence intervals
of each estimate (incidence or prevalence) were calculated
using the standard errors in each year in a region. 
Number of new HFRS case during
September to December in a year
Incidence =
Population at Risk in a region during
the same period [person-months]
Number of total cases among the
military personnel
Total number of military personnel
RESULTS
Surveillance
Civilians
In Yeoncheon, the active surveillance system identified 43
acute febrile patients in 1996; 29 cases were followed up and
5 cases were verified as HFRS. In 1997, 104 acute febrile pa-
tients were initially reported; 45 cases were followed up and
7 were confirmed as HFRS. In 1998, 99 acute febrile patients
were initially enrolled; 33 cases were followed up and 5 pa-
tients were finally diagnosed as HFRS. An additional 9 HFRS
cases were found by reviewing medical records of neighbor-
ing hospitals.
In Paju, 39 acute febrile patients were enrolled in 1998 and
5 of them were confirmed as HFRS. An additional 10 patients
were found by reviewing medical records. More than 70% of
the patients with HFRS were male (male:female=29:12), with
the average age being forty-four years (range, 15 to 93). Annual
population estimates were obtained from the provincial health
department. The population size of Yeoncheon during the
study period was approximately 55,000. The number of in-
Fig. 2. Active surveillance system for HFRS established in endemic areas.
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habitants in Paju was approximately 178,000 in 1998.
The incidence in Yeoncheon, from 1996 to 1998, ranged
from 2.3 to 6.6 per 100,000 person-months. The incidence
in Paju in 1998 was 2.1 per 100,000 person-months. The
incidence was highest in 1998; there also were several cases
admitted to neighboring hospitals. In order to take follow-up
loss cases into account, we calculated the estimated incidence.
The estimated incidence rates in Yeoncheon in 1996 and 1997
were 3.9 and 7.6 per 100,000 person-months, respectively
(Table 1). Since a large number of cases were detected outside
the active surveillance system in 1998, we could not assess
the estimated incidence. Among the HFRS cases, none of
them had history of vaccination against HFRS and only 1 pa-
tient died of the disease.
Military personnel
We assessed the annual prevalence of HFRS in Korean mili-
tary personnel from 1995 to 1998 by analyzing the data ob-
tained from the preexisting HFRS surveillance system in
the AFCH. The annual prevalence varied from 40 to 64 per
100,000 military populations during the study years (Table
2). The highest prevalence was observed in 1998. The cases
occurred predominantly during November and December
each year. Noticeably, minor peaks were also observed in 1995
and 1998 (Fig. 3).
Subclinical infection of Hantaan virus infection and its
seroprevalence
Civilians
Seroepidemiologic surveys were performed among civilians
in the endemic areas in 1997 and 1998. Serum samples and
questionnaires were collected from volunteers in August and
the following February each year. Seroprevalence of Hantaan
virus antibodies before and after the major epidemic period
were 11.0% (49/444) and 12.5% (38/304) in 1997, and 7.0%
(34/486) and 2.7% (10/369) in 1998, respectively. There were
no significant differences between the study areas (Table 3). 
The subclinical infection rates during the major epidemic
periods varied from 10.0% (26/261) in 1997 to 1.4% (5/348)
in 1998 (Table 3). All subclinical cases showed seroconversion
with reciprocal antibody titers ranging from 64 to 1,024.
Three exceptional cases in which more than a four-fold rise in
antibody titer were observed. 
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Fig. 3. Monthly distribution of HFRS cases among Korean military
personnel (1995-1998).
1995
1996
1997
1998
*Incidence rate is presented as 100,000 person-months. 
� Estimated inci-
dence rate of HFRS cases when follow-up loss cases are taken into ac-
count.
Area Study period
No. of
cases
Incidence
(95% CI)*
Incidence, esti-
mated (95% CI)
�
Yeoncheon Sept-Dec, 1996 5 2.3 3.8
(0.3-4.3) (1.2-6.4)
Sept-Dec, 1997 7 3.2 7.4
(0.8-5.5) (3.8-11.0)
Sept-Dec, 1998 14 6.3 -
(3.0-9.7)
Paju Sept-Dec, 1998 15 2.1 -
(1.0-3.2)
Table 1. Incidence of HFRS in civilians from endemic areas dur-
ing the study periods (1996-1998)
Area 1995 1996 1997 1998
Cheorwon 39 62 8 23
Paju 45 27 27 45
Pocheon 13 38 38 25
Incheon 57 57 29 171
Yeoncheon 75 15 46 60
Gimpo 50 50 100 150
Others 66 30 30 84
Average 52 40 40 64
Table 2. Annual prevalence of HFRS in Korean military person-
nel (1995-1998)                                               (cases per 100,000)
*% of civilians with positive serologic tests, but had no HFRS vaccina-
tion for the previous three years. 
� % of civilians with seroconversion or
four-fold rising antibody titer in paired sera, but had no vaccination and
clinical symptoms and signs for HFRS.
Yeoncheon Paju Total % 
(95% CI)
Seroprevalence*
Aug, 1997 12.4 (8.5-16.3) 8.9 (4.6-13.2) 11.0 (8.1-13.9)
Feb, 1998 12.8 (8.3-17.3) 11.8 (5.3-18.4) 12.5 (8.8-16.2)
Aug, 1998 5.9 (3.2-8.7) 8.5 (4.6-12.4) 7.0 (8.8-16.2)
Feb, 1999 2.5 (0.3-4.6) 3.0 (0.4-5.6) 2.7 (1.1-4.4)
Subclinical infection
�
Aug, 1997-Feb, 1998 9.7 (5.4-13.9) 10.7 (3.7-17.7) 10.0 (6.3-13.6)
Aug, 1998-Feb, 1999 1.1 (0.0-2.6) 1.8 (0.0-3.8) 1.4 (0.2-2.7)
Table 3. Seroprevalence and subclinical infection rate (%; 95%
CI) of HFRS among civilians living in two endemic areas before
and after the major epidemic period (1997-1998)618 J.Y. Song, B.C. Chun, S.D. Kim, et al.
Military personnel
To investigate seroprevalence and subclinical infection, a
total of 200 unvaccinated healthy personnel were recruited
in the beginning of the study. Serum samples were collected
in February and August 1995 for the minor epidemic period,
and in August 1996 and February 1997 for the major epi-
demic period. Seroprevalence after the minor epidemic peri-
od in 1995 increased markedly from 2.1% (4/187) in Febru-
ary to 16.4% (30/183) in August. As for the major epidemic
period in 1996, the seroprevalence rose from 2.7% (3/115) to
5.2% (6/116).
The subclinical infection rate for the minor epidemic period
in 1995 was 15.7% whereas the rate for the major epidemic
period in 1996 was 3.5% (Table 4). The higher seroprevalence
and subclinical infection rate after the minor epidemic peri-
od in 1995 suggest an increase in disease activity during this
interval.
Vaccination rate
Civilians
The annual vaccination rate among civilians in Yeoncheon
ranged from 3.7 to 5.5% between 1996 and 1998; in Paju,
it ranged from 1.4 to 1.5% between 1997 and 1998 (Table
5). The vaccination rate was highest in subjects aged between
60 and 70 yr, especially in men.
Military personnel 
Since accessibility to vaccination records of military was
limited, we were only able to assess vaccination rates of four
divisions stationed in endemic areas. The vaccination rate
ranged from 17.6% to 36.3% which was much higher than
that of the civilian population (Table 5).
DISCUSSION
This is the prospective study that describes the epidemiol-
ogy of HFRS in the ROK. This study determines the inci-
dence, prevalence, seroprevalence, and subclinical infection
rate in two high-risk groups, civilians in endemic areas and
military personnel, during the epidemic months of the year.
We identified HFRS cases through the active surveillance
systems established in the endemic areas and the Korean tro-
ops. The incidence in the civilian group ranged from 2.1 to
6.6 per 100,000 person-months during the major epidemic
period from 1996 to 1998. The estimated incidence rates rose
to 3.9-7.6 per 100,000 person-months in Yeoncheon, when
the follow-up loss cases were taken into account. Considering
higher male to female ratio in the follow-up loss cases, the
incidence might have been even higher since HFRS was more
common among males, predominantly between 20 to 60 yr
old (7). 
During the 3-yr study period, HFRS showed the peak inci-
dence in 1998. Although the surveillance system was expect-
ed to find all HFRS cases within the study area, a significant
numbers of cases were detected outside the active surveillance
system. Severe cases showing typical clinical features of HFRS
are likely to escape the surveillance system, because many of
them are directly admitted to university hospitals by their
family members who are well aware of the clinical manifes-
tations of the disease. Accordingly, it was important to review
the medical records of neighboring hospitals to detect addi-
tional HFRS cases. On the other hand, the active surveillance
system is important in detecting the mild to moderate HFRS
cases, which are more likely to go undetected without the
serologic confirmation.
We estimated the prevalence of HFRS instead of incidence
in Korean military personnel because there were limitations
in access to the vaccination records. The annual prevalence
from 1995 to 1998 was 40-64 per 100,000 military person-
nel, based on detection of the hospitalized cases. The hospi-
tal-based surveillance system for HFRS has been maintained
in the AFCH since the 1980s; any symptomatic patients sus-
pected to have HFRS are to be transferred and admitted to
the AFCH. Review of the surveillance data from the ROK
Army showed that the reported cases have distinctly decreased
over the past years: from 166 to 73 cases (average, 130 cases)
per year between 1981 and 1990, and from 59 to 23 cases
per year (average, 37 cases) between 1991 and 1998. HFRS
Study period % (95% CI)
Seroprevalence*
Feb, 1995 2.1 (0.1-4.2)
Aug, 1995 16.4 (11.0-21.8)
Aug, 1996 2.7 (0.0-5.5)
Feb, 1997 5.2 (1.1-9.2)
Subclinical infection
�
Feb, 1995-Aug, 1995 15.7 (10.4-21.1)
Aug, 1996-Feb, 1997 3.5 (0.1-6.9)
Table 4. Seroprevalence and subclinical infection rates of HFRS
in Korean military personnel (1995-1996)
*% of military personnel with a positive serologic test. 
� % of military per-
sonnel with seroconversion or four-fold rising antibody titer in paired sera.
Area Year Vaccination rate (%)
Civilians Yeoncheon 1996 3.7
1997 4.8
1998 5.5
Paju 1997 1.5
1998 1.4
Military personnel Division 1998
A 24.4
B 23.3
C 17.6
D 36.3
Table 5. Vaccination rates in civilians* and military personnel
*≥20 yr of age.Hemorrhagic Fever with Renal Syndrome: Epidemiology 619
has been categorized as a reportable disease since 1997. Al-
though incidence or prevalence studies have not been per-
formed previously, it has been reported that more than 500
cases of HFRS were serologically confirmed annually among
civilians and Korean military personnel in the 1980s (9). There
was some confusion or misunderstanding in the cited data
for hospitalized civilian cases, rising to approximately 1,000
HFRS cases during the early 1990s; serologic tests were per-
formed at several institutes with the samples from the same
patient and each of the results were counted separately and
then erroneously summed. 
The reasons for the recent decrease in HFRS in the ROK
have not been evaluated in depth. Possible related factors are
improvement in the standard of living and housing in rural
areas, ecological changes in rodent populations or other nat-
ural factors, and/or the effect of vaccination. The annual vac-
cination rates in civilians older than 20 yr old in the endemic
areas were 1.4-5.5% during the study period. The vaccination
rate in the military personnel from the 4 divisions of the Army
in 1998 was much higher than civilians, ranging from 17.6
to 30%. Interestingly, the declining trend in the reported
HFRS cases in the ROK Army in recent years is coincident
with the start of vaccination in 1991. However, the effective-
ness of HFRS vaccine should be evaluated in clinical trials. 
There were mild fluctuations in HFRS incidence during
the study period possibly related to the size of infected rodent
population, climate, outdoor activities, and exploitation of
fields and mountains. A seroepizootiologic study has report-
ed annual fluctuating rodents’ population in recent years (22).
The number of rodents trapped in 29 widely separated areas,
including Apodemus agrarius and Apodemus peninsulae, was larger
in 1997 and 1998, compared with those in 1996. The over-
all Hantavirus seroprevalence in trapped rodents was 13.1
to 13.6%. 
Seasonal variation of HFRS is clearly observed in the mili-
tary personnel, with the major peak occurring between Octo-
ber and December and the minor peak between May and July,
which is consistent with previous reports. HFRS occurs thro-
ughout the year, but more than 85% of cases occurred dur-
ing the major and minor epidemic periods (3, 7, 9).
In our seroepidemiologic study, seroprevalence and subclini-
cal infection rates among civilians and military personnel var-
ied every year. The incidence of HFRS was high during the
1998 epidemic period and this seems to be due to low sero-
prevalence (7.0%) in the civilians before the epidemic. Rela-
tively low incidence of HFRS during the 1997 epidemic can
be related to relatively higher seroprevalence of 11%, which
might have conferred immunity to HFRS. Song reported pre-
viously that relatively high subclinical infection rates after
big outbreaks played a significant role in decreasing the inci-
dence of HFRS (23). As shown in our data, seroprevalence
or subclinical infection rates in the civilian population were
higher than those of the military personnel population. This
might be due to perennial exposure of the civilian population
to the high-risk environments compared to the military per-
sonnel who are exposed to the environment for, at most, three
years during their enlistment. Interestingly, the highest sub-
clinical infection rate of 15.7% and relatively high reported
cases found in the military personnel during the minor epi-
demic period in 1995 could be due to possible mass exposure
to a common source of infection. Seroprevalences of HFRS
in the neighboring countries were comparable: 12% in rural
China (24) and 6.2% in Taiwan (25).
According to the Korean CDMR (Communicable Disease
Monthly Report), the reported cases of HFRS have slightly
increased since 1999. 392 cases were reported in 2003 and,
contrary to previous reports, many of them occurred in the
southwestern area of the country (15). However, the CDMR
also included suspected cases in its analysis. Therefore, close
observation is required in the following years.
A limitation of this study is that the analysis of the civilian
population included data from only a 4 month period, from
September to December. This limitation is difficult to over-
come because long-term surveillance of rural civilian popu-
lations is technically challenging. Therefore, to get around
this problem, we determined the exact incidence during the
major epidemic periods when more than 75% of cases occur.
Because of the limitation of this study design, we represent-
ed the incidences in civilians as person-months. However, the
active surveillance system for the military personnel was in
place year-round, making it possible to assess annual preva-
lence in military personnel. 
Our data indicate that the incidence of HFRS in civilian
populations in endemic areas varies every year, depending on
the local seroprevalences and subclinical infection rates. Since
rodents are major reservoirs for transmissions of Hantaan virus,
the seroprevalence of the rodent population should be deter-
mined. Furthermore, the annual population cycle should also
be determined to see how it is linked to annual incidence of
HFRS. As for the military personnel, the prevalence remained
generally the same throughout the study period with seasonal
variations. Since the military personnel are a high risk group
and the vaccination rate is about 30%, this population could
be a good candidate for field trials. Our epidemiologic data
on HFRS will be invaluable for establishing immunization
strategies, immunization program policy, and vaccine effica-
cy studies.
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